AHR and neoplasm: Since a growing body of evidence indicates that AHR activation is involved in the proliferation, survival, migration, and invasion of tumor cells, the inhibition of AHR activation through AHR antagonists has emerged as a broadly efficient therapeutic strategy in experimental oncology.